With reference to the stock exchange announcement from SoftOx Solutions AS ("SoftOx" or the "Company") on March 3, 2023, the webcast presentation, due to take place on March 8, 2023, has been postponed. The Board of Directors and the management are considering different financing solutions and this process will be further addressed during the presentation.
The webcast presentation by management will take place on Tuesday, March 14th at 10:00. Please register for the presentation by contacting ir@soft-ox.com.
The presentation will be held in English and followed by a Q&A session. Questions can be submitted in advance to ir@soft-ox.com.
For further information, please contact:
Geir Almås, Executive Chairman of SoftOx Solutions AS
Christian Harstad, Interim CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of reducing the spread of infection and emergence of antimicrobial resistance. For more information on SoftOx, visit www.soft-ox.com